Show simple item record

dc.contributor.advisorRobert J. McKallip
dc.contributor.authorAdir Mohaban
dc.contributor.authorOlga N. Uchakina
dc.date2020
dc.date.accessioned2020-04-21T01:48:13Z
dc.date.available2020-04-21T01:48:13Z
dc.identifier.urihttps://hdl.handle.net/10898/12174
dc.description.abstractExamining the efficacy of an imatinib and glycyrrhizic acid combination treatment on chronic myelogenous leukemia cell lines. As well as examining the mechanism of action of glycyrrhizic acid.
dc.languageEnglish
dc.subjectSchool of Medicine
dc.titleTargeting Chronic Myelogenous Leukemia with Imatinib and Glycyrrhizic Acid Combination Therapy
dc.typeText
refterms.dateFOA2020-09-29T13:42:38Z


Files in this item

Thumbnail
Name:
S020_Mohaban_Ad_MED.pdf
Size:
568.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record